Ensayo clínico

BAROSTIM THERAPY™ In Heart Failure With Preserved Ejection Fraction

NCT: NCT02876042 · COMPLETED

ID NCTNCT02876042

EstadoCOMPLETED

Fecha de inicio2017-03-23

Finalización2025-11-03

SponsorCVRx, Inc. (INDUSTRY)

First posted2016-08-23

Last updated2026-09-11

Resumen breve

The purpose of this registry (NCT02876042) is to evaluate the effect of BAROSTIM THERAPY with the BAROSTIM NEO system in the commercial setting in subjects recently implanted under the CE-Marked indication for resistant hypertension that also have evidence of heart failure with preserved ejection fraction (HFpEF).

Fuente oficial

Ver en ClinicalTrials.gov →

Datos obtenidos de la API de ClinicalTrials.gov. Para conocer el estado más reciente, consulte el registro oficial.